News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Global equity indices traded near flat in the past hour with low volume and no clear direction.
  • US Treasury yields were little changed, leaving the 10-year yield around recent levels.
  • The dollar index remained steady, showing minimal movement against major currencies.
  • Brent and WTI crude prices showed only minor fluctuations and no clear trend in the last hour.
  • No major economic data releases or central bank remarks occurred in the past hour.
  • No new geopolitical or political developments emerged to move markets during the hour.

Latest Articles

Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC)

Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC)

Regeneron Pharmaceuticals announced encouraging preliminary Phase 1/2 trial results for ubamatamab, a bispecific antibody targeting MUC16 and CD3, in patients with recurrent low-grade serous ovarian cancer (LGSOC). The highest dose cohort demonstrated a 73% objective response rate and 11-month median progression-free survival in heavily pretreated …

Phase 2 COURAGE Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During GLP-1 Receptor Agonist-induced Weight Loss

Phase 2 COURAGE Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During GLP-1 Receptor Agonist-induced Weight Loss

Regeneron Pharmaceuticals announced promising Phase 2 trial results demonstrating that trevogrumab, an anti-myostatin antibody, substantially prevents muscle and lean mass loss associated with semaglutide, a GLP-1 receptor agonist, during weight loss in obese patients. The study revealed up to 70% muscle preservation via MRI and sustained effects o…

Vishay Intertechnology SOT-227 Power Modules Increase Power Conversion Efficiency While Eliminating the Need for PCB Redesigns

Vishay Intertechnology SOT-227 Power Modules Increase Power Conversion Efficiency While Eliminating the Need for PCB Redesigns

Vishay Intertechnology introduced four new power modules utilizing 650 V superjunction MOSFET technology in the SOT-227 package, aimed at improving power conversion efficiency in industrial applications without requiring PCB redesigns. The lineup includes modules in single-switch and low side chopper configurations featuring nominal current ratings…

MaxLinear: Under-the-Radar AI Infra Play with Room to Run

MaxLinear: Under-the-Radar AI Infra Play with Room to Run

MaxLinear has become a quiet beneficiary of hyperscale AI buildouts through optical and electrical interconnects. The company is already showing high-teens to triple-digit segment growth, sits below $10B market cap, and trades with bullish technical momentum. This trade idea outlines a defined long entry at $93.00 with a $110 target and $84 stop, p…

Phaos Technology Holdings (Cayman) Limited Announces Entry Into Securities Purchase Agreement for an Equity Facility of Up to US$10 Million

Phaos Technology Holdings (Cayman) Limited Announces Entry Into Securities Purchase Agreement for an Equity Facility of Up to US$10 Million

Phaos Technology Holdings (NYSE American: POAS), a Singapore-headquartered advanced microscopy technology firm, announced a securities purchase agreement with High West Partners LLC for an equity facility of up to $10 million. The agreement allows Phaos to sell shares to the investor over a 36-month period to fund its operations and growth initiati…

Progress Software Connects Enterprise Knowledge Across Business Systems with New Agentic RAG Capabilities

Progress Software Connects Enterprise Knowledge Across Business Systems with New Agentic RAG Capabilities

Progress Software has launched new capabilities within its Agentic RAG platform, including a Microsoft Teams app, a Smart Agent for autonomous multistep retrieval, and a WordPress plugin to enhance content ingestion and governance. These features aim to improve how enterprises scale AI experiences by connecting knowledge directly across business sy…

Innodata: 45% Pullback Rewires the Risk/Reward – Upgrade to Long

Innodata: 45% Pullback Rewires the Risk/Reward – Upgrade to Long

Innodata (INOD) has fallen roughly 45% from its 2026 peak. That pullback compresses premium multiples on a company growing revenue north of 50% with expanding margins, strong free cash flow and minimal leverage. I’m upgrading to a long trade: entry $65.98, stop $53.00, target $95.00 over a long-term horizon (180 trading days). The trade balances el…

Gogo Responds to Court’s Post-Trial Ruling in SmartSky Litigation

Gogo Responds to Court’s Post-Trial Ruling in SmartSky Litigation

The U.S. District Court has overturned the jury's $22.7 million damages award against Gogo Inc. in the SmartSky litigation, finding that SmartSky failed to prove recoverable damages. This ruling removes significant financial liability for Gogo and helps the company focus on advancing its connectivity technologies for business and government aviatio…

H2O America Completes Texas Subsidiary’s Acquisition of Quadvest

H2O America Completes Texas Subsidiary’s Acquisition of Quadvest

H2O America has completed the acquisition of all assets of Quadvest through its Texas subsidiary, The Texas Water Company, significantly expanding its water and wastewater utility presence in Texas. This acquisition more than doubles H2O America's Texas operations, projecting strong customer growth and enhancing the company's geographically diversi…